BioCryst Pharmaceuticals News

BioCryst Pharmaceuticals | DEFA14A: Others

Apr 26 04:27

BioCryst Pharmaceuticals | DEF 14A: Definitive information statements

Apr 26 04:22

BioCryst Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 28 06:14

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

Feb 26 20:10

BioCryst Pharmaceuticals | 8-K: Current report

Jan 18 13:00

BioCryst Pharmaceuticals | 8-K: Current report

Jan 8 13:00

BioCryst Pharmaceuticals | 8-K: Current report

Dec 1, 2023 20:37

BioCryst Pharmaceuticals | 8-K: Current report

Nov 30, 2023 22:04

BioCryst Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 9, 2023 05:29

BioCryst Pharmaceuticals | 8-K: Current report

Nov 4, 2023 00:16

BioCryst Pharmaceuticals | 8-K: Current report

Nov 4, 2023 00:14

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 2, 2023 19:05

BioCryst Pharmaceuticals | 8-K: Current report

Oct 26, 2023 21:36

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 3, 2023 19:04

BioCryst Pharmaceuticals | 8-K: Current report

Jul 11, 2023 19:00

BioCryst Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 30, 2023 19:33

BioCryst Pharmaceuticals | 8-K: Current report

Jun 14, 2023 19:02

BioCryst Pharmaceuticals | 8-K: BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update

May 3, 2023 19:08

BioCryst Pharmaceuticals | DEFA14A: Others

Apr 28, 2023 04:18

BioCryst Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 28, 2023 04:17